A Wilmot Cancer Institute scientist published data that show a new microchip-like device that his lab developed can reliably model changes in the bone marrow as leukemia takes root and spreads. Ben ...
Leukemia comprises a heterogeneous group of hematologic malignancies characterized by the uncontrolled proliferation of abnormal white blood cells in the bone marrow and blood. Its complex multiscale ...
Tyrosine kinase inhibitors (TKI) are an unprecedented breakthrough for chronic phase-chronic myeloid leukemia (CP-CML) management, but the proportion of patients with insufficient therapeutic response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results